Patents by Inventor Tina Parsons

Tina Parsons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sialyl-di-Lewisas expressed on glycoproteins but not glycolipids as a functional cancer target and antibodies thereto
    Patent number: 10835618
    Abstract: The present invention relates to an isolated specific binding member capable of binding sialyl-di-Lewisa, and associated treatments and pharmaceutical compositions for treatment of cancer.
    Type: Grant
    Filed: August 25, 2016
    Date of Patent: November 17, 2020
    Inventors: Lindy Gillian Durrant, Mireille Vankemmelbeke, Silvana Tivadar, Tina Parsons, Richard McIntosh
  • SIALYL-DI-LEWIS A AS EXPRESSED ON GLYCOPROTEINS BUT NOT GLYCOLIPIDS AS A FUNCTIONAL CANCER TARGET AND ANTIBODIES THERETO
    Publication number: 20180236095
    Abstract: The present invention relates to an isolated specific binding member capable of binding sialyl-di-Lewisa, and associated treatments and pharmaceutical compositions for treatment of cancer.
    Type: Application
    Filed: August 25, 2016
    Publication date: August 23, 2018
    Inventors: Lindy Gillian Durrant, Mireille Vankemmelbeke, Silvana Tivadar, Tina Parsons, Richard McIntosh
  • Monoclonal antibody SC104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent
    Patent number: 8343490
    Abstract: The present invention provides an isolated specific binding member capable of binding a sialyltetraosyl carbohydrate and directly inducing cell death without the need for immune effector cells. Such a binding member may be an antibody or a part thereof. Also provided are the use of such binding members in medicine and nucleic acids encoding such binding members.
    Type: Grant
    Filed: February 3, 2011
    Date of Patent: January 1, 2013
    Assignee: Cephalon Australia Pty Ltd
    Inventors: Linda Gillian Durrant, Tina Parsons
  • Binding member which binds to both lewis-Y and lewis-B haptens, and its use for treating cancer
    Patent number: 8273349
    Abstract: The invention relates to the use of a binding member which binds to LewisY and Lewisb haptens in the treatment of tumours and leukaemia. The binding member may be an antibody which binds to LewisY and Lewisb haptens and cancer cells and induces cells death.
    Type: Grant
    Filed: December 21, 2010
    Date of Patent: September 25, 2012
    Assignee: Cephalon Australia Pty Ltd
    Inventors: Linda Durrant, Tina Parsons
  • Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses
    Patent number: 8187600
    Abstract: The invention relates to the use of a polypeptide that comprises i) a first portion comprising the part of human Fc that binds to CD64, and ii) a second portion comprising one or more heterologous T cell epitopes for stimulating a cytotoxic T cell response. The polypeptide may be an antibody that may be used to stimulate a cytotoxic T cell response against pathogens and tumor cells in patients in need of such treatment.
    Type: Grant
    Filed: August 18, 2010
    Date of Patent: May 29, 2012
    Assignees: Scancell Limited, Cancer Research Technology Limited
    Inventors: Linda Gillian Durrant, Tina Parsons, Adrian Robins
  • Monoclonal Antibody SC104 and Derivative Thereof Specifically Binding to a Sialyltetraosyl Carbohydrate as a Potential Anti-Tumor Therapeutic Agent
    Publication number: 20110212113
    Abstract: The present invention provides an isolated specific binding member capable of binding a sialyltetraosyl carbohydrate and directly inducing cell death without the need for immune effector cells. Such a binding member may be an antibody or a part thereof. Also provided are the use of such binding members in medicine and nucleic acids encoding such binding members.
    Type: Application
    Filed: February 3, 2011
    Publication date: September 1, 2011
    Inventors: Linda Gillian Durrant, Tina Parsons
  • Polypeptides capable of binding to CD64 comprising one or more heterologous T cell epitopes and their uses
    Publication number: 20110165180
    Abstract: The invention relates to the use of a polypeptide that comprises i) a first portion comprising the part of human Fc that binds to CD64, and ii) a second portion comprising one or more heterologous T cell epitopes for stimulating a cytotoxic T cell response. The polypeptide may be an antibody that may be used to stimulate a cytotoxic T cell response against pathogens and tumour cells in patients in need of such treatment.
    Type: Application
    Filed: August 18, 2010
    Publication date: July 7, 2011
    Applicants: Scancell Limited, Cancer Research Technology Ltd
    Inventors: Linda Gillian Durrant, Tina Parsons, Adrian Robins
  • BINDING MEMBER WHICH BINDS TO BOTH LEWIS-Y AND LEWIS-B HAPTENS, AND ITS USE FOR TREATING CANCER
    Publication number: 20110150906
    Abstract: The invention relates to the use of a binding member which binds to LewisY and Lewisb haptens in the treatment of tumours and leukaemia. The binding member may be an antibody which binds to LewisY and Lewisb haptens and cancer cells and induces cells death.
    Type: Application
    Filed: December 21, 2010
    Publication date: June 23, 2011
    Inventors: LINDA Gillian DURRANT, Tina Parsons
  • Monoclonal antibody Sc104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent
    Patent number: 7915387
    Abstract: The present invention provides an isolated specific binding member capable of binding a sialyltetraosly carbohydrate and directly inducing cell death without the need for immune effector cells. Such a binding member may be an antibody or a part thereof. Also provided are the use of such binding members in medicine and nucleic acids encoding such binding members.
    Type: Grant
    Filed: May 11, 2005
    Date of Patent: March 29, 2011
    Assignee: Cephalon Australia Pty Ltd
    Inventors: Linda Gillian Durrant, Tina Parsons
  • Binding member which binds to both Lewis-and Lewis-haptens, and its use for treating cancer
    Patent number: 7879983
    Abstract: The invention relates to the use of a binding member which binds to Lewisy and Lewisb haptens in the treatment of tumours and leukaemia. The binding member may be an antibody which binds to Lewisy and Lewisb haptens and cancer cells and induces cells death.
    Type: Grant
    Filed: July 17, 2009
    Date of Patent: February 1, 2011
    Assignee: Cephalon Australia Pty Ltd
    Inventors: Linda Durrant, Tina Parsons
  • BINDING MEMBER WHICH BINDS TO BOTH LEWIS-Y AND LEWIS-B HAPTENS, AND ITS USE FOR TREATING CANCER
    Publication number: 20090281285
    Abstract: The invention relates to the use of a binding member which binds to Lewisy and Lewisb haptens in the treatment of tumours and leukaemia. The binding member may be an antibody which binds to Lewisy and Lewisb haptens and cancer cells and induces cells death.
    Type: Application
    Filed: July 17, 2009
    Publication date: November 12, 2009
    Inventors: Linda Gillian Durrant, Tina Parsons
  • Monoclonal Antibody Sc104 and Derivative Thereof Specifically Binding to a Sialyltetraosyl Carbohydrate as a Potential Anti-Tumor Therapeutic Agent
    Publication number: 20080118509
    Abstract: The present invention provides an isolated specific binding member capable of binding a sialyltetraosly carbohydrate and directly inducing cell death without the need for immune effector cells. Such a binding member may be an antibody or a part thereof. Also provided are the use of such binding members in medicine and nucleic acids encoding such binding members.
    Type: Application
    Filed: May 11, 2005
    Publication date: May 22, 2008
    Inventors: Linda Gillian Durrant, Tina Parsons
  • BINDING MEMBER WHICH BINDS TO BOTH LEWIS-Y AND LEWIS-B HAPTENS, AND ITS USE FOR TREATING CANCER
    Publication number: 20080085278
    Abstract: The invention relates to the use of a binding member which binds to Lewisy and Lewisb haptens in the treatment of tumours and leukaemia. The binding member may be an antibody which binds to Lewisy and Lewisb haptens and cancer cells and induces cells death.
    Type: Application
    Filed: July 31, 2007
    Publication date: April 10, 2008
    Inventors: Linda Durrant, Tina Parsons
  • Binding member which binds to both Lewisand Lewishaptens, and its use for treating cancer
    Patent number: 7267821
    Abstract: The invention relates to the use of a binding member which binds to Lewisy and Lewisb haptens in the treatment of tumours and leukaemia. The binding member may be an antibody which binds to Lewisy and Lewisb haptens and cancer cells and induces cells death.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: September 11, 2007
    Assignee: Scancell Limited
    Inventors: Linda Gillian Durrant, Tina Parsons
  • Binding member which binds to both lewis-y and lewis-b haptens, and its use for treating cancer
    Publication number: 20040185052
    Abstract: The invention relates to the use of a binding member which binds to Lewisy and Lewisb haptens in the treatment of tumours and leukaemia. The binding member may be an antibody which binds to Lewisy and Lewisb haptens and cancer cells and induces cells death.
    Type: Application
    Filed: May 14, 2004
    Publication date: September 23, 2004
    Inventors: Linda Gillian Durrant, Tina Parsons
  • Substances
    Publication number: 20040146505
    Abstract: The invention relates to the use of a polypeptide which comprises i) a first portion comprising the part of human Fc which binds to CD64, and ii) a second portion comprising one or more heterologous T cell epitopes for stimulating a cytotoxic T cell response. The polypeptide may be an antibody which may be used to stimulate an cytotoxic T cell response against pathogens and tumour cells in patients in need of such treatment.
    Type: Application
    Filed: January 21, 2004
    Publication date: July 29, 2004
    Inventors: Linda Gillian Durrant, Tina Parsons, Adrian Robins